Yoni Biotechnology Inc.

What Yoni Biotechnology Inc. does

Yoni Biotechnology Inc. is a privately held Canadian company developing a non-invasive wearable biosensor paired with a companion mobile application for continuous, real-time monitoring of hormones and related biomarkers in women. The company's stated focus spans menstrual health, fertility, and menopause, with the goal of producing high-resolution, longitudinal hormone data that conventional episodic testing cannot capture. Its core technology combines a nanotechnology-based biosensor with proprietary data analysis algorithms that map hundreds of health markers and symptoms simultaneously to surface patterns that are not visible through standard clinical workups. The company was founded by CEO Aditi Basdeo following a personal experience with delayed PCOS diagnosis and frames its mission around addressing the historical underrepresentation of women in health research.

The intended business model is a two-stream structure: hardware sales of the wearable biosensor and a recurring subscription for the companion app, which delivers personalized predictions, cycle and symptom tracking, and shareable summaries with healthcare providers. Distribution is planned as direct-to-consumer, with secondary outreach to clinical researchers. The product is not yet commercialized; R&D and clinical validation are currently conducted through partnerships with Western Engineering, St. Joseph's Hospital, and London Health Sciences Centre in Ontario, Canada. Pricing has not been publicly disclosed, no external funding rounds are recorded, and the operating team consists of approximately five members spanning hardware, software, product design, and market research under the founder.

Name

Yoni Biotechnology Inc.

Legal name

Yoni Biotechnology Inc.

Website

https://yonibiotech.ca

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Yoni Biotechnology Inc. is a Canadian pre-revenue company developing a non-invasive wearable biosensor and companion mobile app for continuous, real-time hormone monitoring in women across menstrual, fertility, and menopause life stages.

Ownership category

akta.pro rank

Product category

Women's Health Technology

NAICS

Other Measuring and Controlling Device Manufacturing (334519), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in Nanotechnology (541713)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro industry

PRIMARYHLAAAMAL

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)

Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

SECONDARYHDAHALAK

Biosensors & Lab-on-Chip (BioMEMS)

Hardware, Technology & Telecom/Semiconductors & Electronic Components/Sensors, MEMS & Optoelectronics

Keywords

• Women's health monitoring
• Hormone biosensor technology
• Wearable health sensors
• Fertility tracking devices
• Menstrual health platform

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain

Revenue model

1. Wearable Biosensor Device: Sale of a wearable non-invasive hormone monitoring device. Hardware product currently in development.
2. Mobile Application and Intelligence Platform: Subscription-based app providing personalized predictions, actionable insights, and trend analysis based on continuous hormone monitoring data. Connects sensor data with symptoms and lab results.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Yoni Biotechnology Inc. is developing a non-invasive wearable biosensor that continuously tracks key hormones and related biomarkers in real time, paired with a companion mobile application that connects hormone signals with symptoms, cycle data, and lab results. The platform uses nanotechnology and intelligent algorithms to deliver personalized predictions, trend analysis, and shareable healthcare provider summaries for women's health management across menstruation, fertility, and menopause life stages.

Product overview

Yoni Biotechnology Inc. offers a unified platform consisting of two core products: the Yoni Biosensor (a non-invasive wearable device for continuous hormone monitoring) and the Yoni App (a companion mobile application that connects biomarker signals with symptoms and labs). Together, these products provide real-time hormone tracking, personalized predictions, and actionable insights for women's health management across menstruation, fertility, and menopause.

Differentiator

Problem solved

Functional benefit

Products and services

• Yoni Biosensor A non-invasive wearable biosensor that continuously tracks key hormones and related biomarkers in real time, designed to support women's health from menstruation through menopause.
• Yoni App A companion mobile application that connects hormonal and biomarker signals with symptoms, cycle data, and lab results, providing personalized predictions, actionable insights, trend analysis, and shareable summaries for healthcare providers.

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Western EngineeringcoreTechnology or IntegrationTechnology development partnership for the non-invasive biosensor and data analysis technology. Currently in development with Western Engineering as a key R&D partner.
• St. Joseph's HospitalcoreStrategic or Co-development PartnerClinical development partner for hormone monitoring technology validation. Currently in development with St. Joseph's Hospital for clinical integration and evidence-based care development.
• London Health Sciences CentrecoreStrategic or Co-development PartnerClinical development partner for continuous hormone monitoring validation. Partnering to advance evidence-based care for women through clinical research and integration.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Mira: Mira provides at-home quantitative hormone monitoring (LH, E3G, PdG, FSH) via a handheld device and app for fertility tracking. Direct peer in continuous hormone sensing for women's reproductive health, though using urine rather than Yoni's biosensor approach.
• Natural Cycles: Natural Cycles is an FDA-cleared fertility tracking app that uses basal body temperature and cycle data for contraception/conception. Directly comparable to Yoni's cycle and fertility prediction use cases with a similar consumer subscription model.
• Inito: Inito offers an at-home fertility monitor that tracks multiple hormones (E3G, LH, PdG, FSH) from urine on test strips. Direct peer in quantitative hormone monitoring for cycle/fertility with a connected app, and a useful emerging comparison point.
• Tempdrop: Tempdrop is a wearable fertility and cycle tracking sensor worn overnight to capture continuous basal body temperature. Closely comparable to Yoni's non-invasive continuous hormone/cycle monitoring concept for the same target buyer.
• Ava Science: Ava makes a fertility-tracking bracelet that continuously collects physiological data (skin temperature, heart rate, etc.) to predict fertile windows. It is the closest direct peer to Yoni's wearable continuous-monitoring approach for women's reproductive health.
• Proov: Proov sells at-home PdG (progesterone metabolite) tests and a connected app for confirming ovulation and cycle health. Direct peer in the women's hormonal health monitoring category with a subscription/test kit revenue model.

Broad incumbents

• Whoop: Whoop offers a subscription-based continuous wearable for recovery, sleep, and strain. Not hormone-specific, but a comparable continuous-wearable subscription model and brand in the broader women's health/wellness category Yoni is moving into.
• Oura: Oura makes a smart ring that continuously tracks sleep, heart rate, temperature, and (recently) women's health/cycle insights. It is a broader incumbent in continuous wearable health monitoring rather than a hormone-specific peer, but a key adjacent competitor for share-of-wallet.
• Apple (Apple Watch Cycle Tracking): Apple Watch includes cycle tracking, temperature sensing (via sensor), and general health monitoring on a massive consumer install base. It is not hormone-specific, but as a broad incumbent it sets consumer expectations for cycle/fertility features and competes for the same end user.

Emerging players

• Eli Health: Eli Health is building at-home continuous hormone monitoring (saliva-based) for women's health. Highly comparable emerging player in the same continuous hormone-monitoring category Yoni is targeting.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/yonibiotech
• Instagraminstagram.com/yonibiotech

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Yoni Biotechnology Inc.